MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Amortizatization of Intangibles (2022 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Amortizatization of Intangibles came in at $27000.0 in Q4 2025, up 104.39% YoY from $13210.0 in Q4 2024, and up 106.34% on a QoQ basis from -$426000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Amortizatization of Intangibles (2022 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 4 years of Amortizatization of Intangibles data on file, last reported at $27000.0 in Q4 2025.

  • Quarterly Amortizatization of Intangibles rose 104.39% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $153000.0 (down 26.79% YoY) and the FY2025 annual result came in at $153000.0, down 26.79% from the prior year.
  • Amortizatization of Intangibles climbed to $27000.0 in Q4 2025, from -$426000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $498000.0 in Q2 2024 to a low of -$615000.0 in Q4 2024.
  • A 4-year average of $41307.7 and a median of $47000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 2450.0% — and 2024, when it plunged 1408.51%.
  • Tracing MGTX's Amortizatization of Intangibles over 4 years: stood at -$2000.0 in 2022, then soared by 2450.0% to $47000.0 in 2023, then sank by 1408.51% to -$615000.0 in 2024, then jumped by 104.39% to $27000.0 in 2025.
  • The last three Amortizatization of Intangibles figures came in at $27000.0 (Q4 2025), -$426000.0 (Q3 2025), and $489000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 283,000.00
Sep 30, 2025 282,000.00
Jun 30, 2025 278,000.00
Mar 31, 2025 274,000.00
Dec 31, 2024 279,000.00
Sep 30, 2024 278,000.00
Jun 30, 2024 273,000.00
Mar 31, 2024 273,000.00
Dec 31, 2023 274,000.00
Sep 30, 2023 271,000.00
Jun 30, 2023 272,000.00
Mar 31, 2023 266,000.00
Dec 31, 2022 274,000.00